Stock Ratings / Health Care / NRC / insiders

OABI (38) MXCT (30) ABSI (45) ONMD (29) ⌘ Pro Terminal →

NRC Health (NRC) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

$23.49 +0.09% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)

NRC Health (NRC) carries a Roarable Rating of C (Hold) with 65/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

ROARABLE C • HOLD / WATCH Cap $519.6M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERHOLD / WATCH • C

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw B- · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE+3.2% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for NRC)Realized 20D OHLCV Swing Band: ±9%

SEC FORM 4 × 13F HEDGE FUNDS × CONGRESSIONAL STOCK ACT

NRC Smart-Money Thermometer: BALANCED INSTITUTIONAL POSITIONING

Explore All 13F & Congress Whales →

▲ Disclosed Buys: 0 ($0)▼ Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (NRC)

No recent open-market Form 4 cluster sales or emergency dumps flagged on NRC. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (NRC Tape Review)

✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
✓Forensic Red-Light accounting & dilution traps to review on your watchlist
✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

NRC // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +42.71%▲ ASCENDING CHANNEL

2026-10-30O $23.64H $24.01L $23.47C $23.49VOL 86.2K

RES: $28.08SUP: $19.92SMA50: $21.22SMA200: $19.17

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

NRC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 NRC Butterfly Map → + Track NRC →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

33.4%/yr Implied 5Y Growth

vs. -4.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on NRC today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for NRC. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for NRC today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (NRC)

Health Care Rank #137 of 1016 ⚔️ OABI vs NRC Full Matrix →

1. Head-to-Head Health Care Peer Comparison (NRC vs. OABI, MXCT, ABSI, ONMD)

Industry: Biotechnology: Commercial Physical & Biological Resarch (12 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, NRC Health (NRC) ranks #137 by composite RQD confidence (65/100, grade C) and #440 by equity capitalization ($519.6M). Within this direct 5-issuer industry benchmark cohort, NRC leads on earnings valuation at 44.8x trailing P/E, while NRC leads on capital efficiency and profitability with 21.0% ROIC and — gross margin. NRC currently leads its immediate peer cohort in composite quantitative strength at 65/100 (C).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
NRC ACTIVE NRC Health	C	65/100	44.8x	—	21.0%	+0.09%	$519.6M	Benchmark Subject
OABI OmniAb Inc.	D-	38/100	—	—	-22.6%	-0.95%	$760.4M	/oabi-vs-nrc →
MXCT MaxCyte Inc.	E	30/100	—	96.0%	-27.1%	+1.17%	$178.5M	/mxct-vs-nrc →
ABSI Absci Corporation	D	45/100	—	—	-35.0%	+1.85%	$2.08B	/absi-vs-nrc →
ONMD OneMedNet Corp (Class A)	E	29/100	—	-30.0%	-35.0%	-2.02%	$26.3M	/onmd-vs-nrc →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000070487

In its most recent audited fiscal period (FY2025, filed 2025-12-31), NRC Health (NRC) reported GAAP revenue of $137.4M (-4.0% vs. FY2024 revenue of $143.1M , and -7.5% cumulative change since FY2023) , GAAP net income of $11.6M, operating cash flow of $26.4M, and free cash flow of $15.7M (-17.9% YoY). On the balance sheet, NRC closed FY2025 with $134.9M in total assets against $75.0M in total debt (Altman Z-Score: 3.82, Piotroski F-Score: 4/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$137.4M	$11.6M	$26.4M	$15.7M	$134.9M	$75.0M
FY2024 (FY)	2024-12-31	$143.1M	$24.8M	$34.6M	$19.2M	$132.5M	$57.9M
FY2023 (FY)	2023-12-31	$148.6M	$31.0M	$38.1M	$38.1M	—	—

3. NRC Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is NRC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, NRC Health (NASDAQ: NRC) is rated C (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 65/100 at a spot price of $23.49 (+0.09% 1D, market cap $519.6M). Pillar breakdown: Fundamental Cash Engine 18/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 12/20, FRED Macro Regime Fit 11/20, and SEC Balance-Sheet Forensics 12/20. Across 1016 tracked Health Care issuers, NRC ranks #137 in composite RQD confidence.

How does NRC compare to OABI and MXCT in the Health Care sector?

Within the Health Care sector (Biotechnology: Commercial Physical & Biological Resarch), NRC carries a Roarable C (65/100 RQD), trailing P/E of 44.8x, gross margin of —, and ROIC of 21.0%. By comparison, OABI (OmniAb Inc.) holds a D- grade (38/100 RQD, P/E N/A, ROIC -22.6%, cap $760.4M) and MXCT (MaxCyte Inc.) posts a E grade (30/100 RQD, P/E N/A, ROIC -27.1%, cap $178.5M). Among the 5-stock peer group, NRC leads on earnings multiple (44.8x) while NRC leads on capital efficiency (21.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for NRC?

Per NRC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000070487), NRC Health generated $137.4M in revenue (-4.0% YoY), $11.6M in net income, and $15.7M in free cash flow against $134.9M in total assets and $75.0M in total debt. Key quantitative strengths: Strong cash generator (steady margins)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Priced at 45x earnings—high expectations leave less room for a lukewarm quarter.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is NRC trading relative to its 50-day, 200-day, and 52-week technical levels?

NRC last traded at $23.49 (+0.09% on volume of 124,957 shares), positioning the stock +10.70% above its 50-day simple moving average ($21.22) and +22.54% above its 200-day simple moving average ($19.17). Across its 52-week range of $11.74 to $24.40, NRC sits at the 92.8% percentile with a 14-day RSI of 66.7 (BULLISH MOMENTUM) and an implied next-earnings move of ±9.0% ($21.38 to $25.60).

NRC Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Are NRC insiders and hedge funds buying or selling?

Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies NRC leadership and institutional positioning as: BALANCED INSTITUTIONAL POSITIONING.

Direct Sub-Reports: NRC RQD Cockpit NRC 12M Forecast NRC Earnings & Move NRC Dividends & DRIP NRC Insiders & 13F NRC Whale Options NRC Profit Sankey NRC News & Why